This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Lisa Deschamps
SVP, Chief Business Officer at Novartis Gene Therapies


Lisa is responsible for strategic planning and worldwide commercialization of pipeline and in-line assets across the extensive gene therapy portfolio within Novartis Gene Therapies (formerly AveXis). This includes managing significant revenue growth targets and profitability margins world-wide.

Prior to this role, Lisa was the Head of the Global Neuroscience Franchise.  During her 25-year career at Novartis, Lisa has successfully brought highly specialized biologic and small molecule products from the clinic to commercialization in the areas of Cardiovascular, Respiratory, Rheumatology/Immunology and Neurology, including rare and Ultra-Rare disease areas.  Throughout her tenure, Lisa has worked and led teams across U.S, Europe, LatCan and Asia/Pac in Strategic, Functional and General Management roles.

Lisa leads and serves on a number of executive teams across commercial and development within Novartis.  She has garnered many industry awards and honors and has a number of philanthropic interests including domestic violence and pediatric cancer.  

Lisa has an MBA in General Management from NYU Stern School of Business and a BBA in marketing from IONA College, Hagan School of Business 

Agenda Sessions

  • PANEL: Reimbursement Models for Novel Therapies